BACKGROUND: This is a progress report of the Alzheimer's Disease Neuroimaging Initiative
(ADNI) positron emission tomography (PET) Core. METHODS: The Core has supervised …

Various biomarkers are available to support the diagnosis of neurodegenerative diseases
in clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET, …

… In fact, only during the last decade have these children’s social skill deficits been the focus
of serious inquiry. As recently as 1982, Milich and Landau reviewed the literature addressing …

… reliable data and information, neither the author[s] nor the publisher can accept any legal …
’s own judgement, their knowledge of the patient’s medical history, relevant manufacturer’s …

Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

Objective: Using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
population, we examined (1) cross‐sectional relationships between amyloid deposition, …

The Functional Activities Questionnaire (FAQ) and Alzheimer's Disease Assessment Scale—cognitive
subscale (ADAS-cog) are frequently used indices of cognitive decline in …

Background Concerns have been raised about the psychological effect of continued combat
exposure and of repeated deployments. We examined the consequences of deployment to …

… When the media report PET study outcomes like Landau et al.'s, I have to explain to patients
and their families that it is as much science as science fiction. The science may be true, but …

It is not known exactly where amyloid-β (Aβ) fibrils begin to accumulate in individuals with
Alzheimer’s disease (AD). Recently, we showed that abnormal levels of Aβ42 in cerebrospinal …